| Issue Date | 27 Jul 2021 - 29 Jul 2021 |
| Issue Size | ₹1513.6 Cr |
| Issue Price | ₹695-720 |
| Market Lot | 20 Shares |
| Shares on Offer | |
| Registrar | KFintech |
| GMP | ₹145-150 |
| Kostak | ₹350 |
| Subject to Sauda | ₹1600 |
| Listing Date | 06 Aug 2021 |
| Listing Price | ₹751.10 |
| Listing Gain% | 4.17 |
They are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, they have established strong relationships with leading global generic pharmaceutical companies that have helped us expand their product offerings and geographic reach. They work with 16 of the 20 largest generic companies globally.
Their Company is promoted by Chintan Shah, Ajay Patel and Shekhar Somani, who each have over 24 years in the specialty chemicals manufacturing industry and have established strong business relationships with domestic as well as overseas customers. In addition, they are led by a well – qualified and experienced management team, which they believe has demonstrated its ability to manage and grow their operations and has substantial experience in the sectors in which they operate. They believe that the knowledge and experience of their management team provides us with a significant competitive advantage as they seek to grow their business.
Glenmark Pharmaceuticals Limited is the promoter of the company.
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Total Assets (In ₹ Millions) | 19,970.75 | 17,256.04 | 14,753.95 |
| Total Revenue (In ₹ Millions) | 18,859.76 | 15,493.03 | 8,868.65 |
| Profit After Tax (PAT) (In ₹ Millions) | 3,515.81 | 3,130.98 | 1,955.92 |
| Date | GMP | Kostak | Subject to Sauda |
|---|---|---|---|
| 30 Jul 2021 | ₹145-150 | ₹350 | ₹1600 |
| 29 Jul 2021 | ₹115-117 | ₹250-300 | ₹1200-1400 |
| 28 Jul 2021 | ₹114-115 | N/A | N/A |
| 24 Jul 2021 | ₹190-200 | ₹350 | ₹2400-2600 |
| 21 Jul 2021 | N/A | ₹400 | N/A |
| Strength |
|---|
| Weakness |
|---|
| Date & Time | QIB | NII | RII | Total |
|---|---|---|---|---|
| Day 1 - 27 Jul 2021 | 0.00 | 0.86 | 5.17 | 2.78 |
| Day 2 - 28 Jul 2021 | 1.38 | 3.39 | 9.28 | 5.78 |
| Day 3 - 29 Jul 2021 | 36.97 | 122.54 | 14.63 | 44.17 |
Please click the link below to check the IPO allotment status.
IPO Allotment StatusGlenmark Life Sciences Limited IPO will open on 27 Jul 2021 and close on 29 Jul 2021.
Glenmark Life Sciences Limited IPO will list on 06 Aug 2021.
The offer price of Glenmark Life Sciences Limited IPO is ₹695-720.
The lot size of Glenmark Life Sciences Limited IPO is 20.
The Grey Market Premium (GMP) price of Glenmark Life Sciences Limited IPO is ₹145-150.
The Kostak price of Glenmark Life Sciences Limited IPO is ₹350.
The Subject to Sauda price for Glenmark Life Sciences Limited IPO is ₹1600.
Please Leave Your Message
Glenmark Life Sciences Limited IPO Review/Comments